Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Polzer

Showing results (11-20 of 14) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 14 results.
Antimicrobial Agents and Chemotherapy|December 1, 1996
Activity of the new fluoroquinolone trovafloxacin (CP-99,219) against DNA gyrase and topoisomerase IV mutants of Streptococcus pneumoniae selected in vitroT D Gootz, R Zaniewski, S Haskell, et al.
Current Topics in Medicinal Chemistry|May 29, 2003
The role of absorption, distribution, metabolism, excretion and toxicity in drug discoveryJing Lin, Diana C Sahakian, Sonia M F de Morais, et al.
Antimicrobial Agents and Chemotherapy|March 1, 1997
In vivo efficacy of trovafloxacin (CP-99,217), a new quinolone, in experimental intra-abdominal abscesses caused by Bacteroides fragilis and Escherichia coliH Thadepalli, U Reddy, S K Chuah, et al.
Mabs|May 28, 2016
Utility of a human FcRn transgenic mouse model in drug discovery for early assessment and prediction of human pharmacokinetics of monoclonal antibodiesLindsay B Avery, Mengmeng Wang, Mania S Kavosi, et al.
Pageof 2

Showing results (11-20 of 14) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 14 results.
Antimicrobial Agents and Chemotherapy|December 1, 1996
Activity of the new fluoroquinolone trovafloxacin (CP-99,219) against DNA gyrase and topoisomerase IV mutants of Streptococcus pneumoniae selected in vitroT D Gootz, R Zaniewski, S Haskell, et al.
Current Topics in Medicinal Chemistry|May 29, 2003
The role of absorption, distribution, metabolism, excretion and toxicity in drug discoveryJing Lin, Diana C Sahakian, Sonia M F de Morais, et al.
Antimicrobial Agents and Chemotherapy|March 1, 1997
In vivo efficacy of trovafloxacin (CP-99,217), a new quinolone, in experimental intra-abdominal abscesses caused by Bacteroides fragilis and Escherichia coliH Thadepalli, U Reddy, S K Chuah, et al.
Mabs|May 28, 2016
Utility of a human FcRn transgenic mouse model in drug discovery for early assessment and prediction of human pharmacokinetics of monoclonal antibodiesLindsay B Avery, Mengmeng Wang, Mania S Kavosi, et al.
Pageof 2